Holen Sie sich die Stockscreener-App
25.43
6.15%
-1.665
Handel nachbörslich:
25.43
Oculis Holding Ag Aktie (OCS) Neueste Nachrichten
Risk Off: Can Oculis Holding AG beat the S P 500Portfolio Risk Report & Weekly Setup with High ROI Potential - baoquankhu1.vn
Avoiding Lag: Real-Time Signals in (OCS) Movement - Stock Traders Daily
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities - marketscreener.com
Aug Opening: What is the implied volatility of Oculis Holding AG Equity WarrantWeekly Investment Report & Safe Capital Investment Plans - baoquankhu1.vn
H.C. Wainwright raises Oculis stock price target to $44 on trial progress - Investing.com Nigeria
Biopharma companies hire new legal executives - BioXconomy
Oculis (NASDAQ:OCS) Sees Large Volume IncreaseHere's What Happened - MarketBeat
OCS: Late-stage pipeline targets DME, dry eye, and neuroprotection, with major data readouts in 2024 - TradingView
A Look At Oculis Holding (OCS) Valuation After Breakthrough Therapy Status And Q4 2025 Update - Sahm
Oculis (OCS) – Research Analysts’ Recent Ratings Updates - Defense World
Oculis Holding (NasdaqGM:OCS) Valuation Check After Strong Three Year Gains And Recent Share Price Pullback - Yahoo Finance
Oculis (NASDAQ:OCS) Downgraded by Wall Street Zen to "Sell" - MarketBeat
Lifesci Capital Has Negative Estimate for Oculis Q1 Earnings - Defense World
Lifesci Capital Estimates Oculis' Q1 Earnings (NASDAQ:OCS) - MarketBeat
HC Wainwright Weighs in on Oculis' Q1 Earnings (NASDAQ:OCS) - MarketBeat
Why Oculis (OCS) Is Down 6.2% After New Equity Programs To Fund Late-Stage Trials - Sahm
Oculis (NASDAQ:OCS) Releases Quarterly Earnings Results, Misses Expectations By $0.08 EPS - MarketBeat
H.C. Wainwright raises Oculis stock price target to $44 on trial progress By Investing.com - Investing.com South Africa
Oculis Holding AG to Showcase Late-Stage Portfolio and Strategic Developments at March Investor Conferences - Quiver Quantitative
Oculis Publishes 2025 Consolidated Financial Statements - Yahoo Finance
Oculis Holding AG renews $100 million at-the-market offering program - Investing.com Australia
Stifel raises Oculis stock price target to $50 on pipeline progress - Investing.com Nigeria
Oculis Holding AG renews $100 million at-the-market offering program By Investing.com - Investing.com South Africa
Oculis Files 2025 Financials and Renews $100 Million ATM Program - TipRanks
Oculis Holding (NASDAQ: OCS) widens loss but ends 2025 with strong cash and $100m ATM capacity - Stock Titan
Oculis price target raised to $44 from $42 at H.C. Wainwright - TipRanks
Oculis (NASDAQ: OCS) 2025 20-F details losses, cash and trials - Stock Titan
HC Wainwright Issues Positive Forecast for Oculis (NASDAQ:OCS) Stock Price - MarketBeat
Oculis (NASDAQ:OCS) Stock Price Expected to Rise, Needham & Company LLC Analyst Says - MarketBeat
Chardan Raises Price Target on Oculis Holding to $53 From $51, Keeps Buy Rating - marketscreener.com
Oculis Holding's Q4 Net Loss Narrows; Plans Phase 3 Trial Readouts For OCS-01 In Q2,2026 - Nasdaq
Oculis Reports Q4 and Full-Year 2025 Results, Shares Update - InvisionMag.com
Oculis Posts 2025 Results, Extends Cash Runway and Advances Late-Stage Ophthalmology Pipeline - TipRanks
Oculis Holding AG (OCS) Reports Q4 Loss, Tops Revenue Estimates - Yahoo Finance
Oculis reports Q4 EPS (CHF 0.42c) vs. (CHF 0.67) last year - TipRanks
Oculis Reports Q4 and Full Year 2025 Financial Results and Provides Company Update - The Manila Times
[6-K] Oculis Holding AG Current Report (Foreign Issuer) | OCS SEC FilingForm 6-K - Stock Titan
Eye drug firm Oculis eyes 3 major 2026 vision milestones after $119M loss - Stock Titan
Oculis (OCS) to Release Quarterly Earnings on Tuesday - MarketBeat
Oculis Holding AG (NASDAQ:OCS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Earnings To Watch: Oculis Holding AG (OCS) Reports Q4 2025 Resul - GuruFocus
Discipline and Rules-Based Execution in OCS Response - Stock Traders Daily
Oculis Holding AG expected to post a loss of 42 rappen a shareEarnings Preview - TradingView
Oculis (NASDAQ:OCS) Sets New 12-Month HighHere's What Happened - MarketBeat
Bull Bear: Can Oculis Holding AG continue delivering strong returnsJuly 2025 Macro Moves & Community Trade Idea Sharing Platform - baoquankhu1.vn
Big Picture: Will Oculis Holding AG benefit from green energy policiesTrade Risk Report & Fast Entry Momentum Alerts - baoquankhu1.vn
Will Oculis Holding AG benefit from green energy policiesMarket Activity Recap & Fast Gain Stock Tips - mfd.ru
Oculis Holding AG (OCS) Investor Outlook: Analyst Ratings Signal a 59.98% Upside Potential - DirectorsTalk Interviews
Fund Flows: Whats the profit margin of Oculis Holding AG Equity Warrant2025 Top Decliners & Low Risk High Win Rate Picks - baoquankhu1.vn
Oculis (NASDAQ:OCS) Hits New 1-Year HighHere's Why - MarketBeat
Aug EndMonth: Can Oculis Holding AG beat the S P 5002025 Major Catalysts & Daily Risk Controlled Trade Plans - baoquankhu1.vn
Oculis Publishes Notifications of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated - Yahoo Finance UK
Behavioral Patterns of OCS and Institutional Flows - Stock Traders Daily
0.48%
1.21%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):